Your session is about to expire
← Back to Search
Cognitive Training for ADHD (CogtrainADHD Trial)
CogtrainADHD Trial Summary
This trial looks at how well cognitive training works for people with ADHD in Switzerland.
- Attention Deficit Hyperactivity Disorder (ADHD)
CogtrainADHD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCogtrainADHD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CogtrainADHD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- This text refers to people aged between 6 and 65 years old.You cannot be taking medication for ADHD.You are not currently taking medication for ADHD.You are currently taking medication or have previously taken medication for ADHD.An IQ score of 80 or above is considered above average for adults, children, and adolescents, according to the Wechsler Intelligence Scales.You have not been diagnosed with ADHD by a specialist.You are currently taking medication or receiving treatment for ADHD.You have not been diagnosed with ADHD by a specialist.You have been diagnosed with ADHD by a specialist.
- Group 1: active control group low-intensity
- Group 2: control healthy participants
- Group 3: experimental training group cognitive training
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What outcome is the research team aiming to achieve with this clinical investigation?
"This clinical trial will primarily assess the impact of cognitive training on ADHD symptomology for children over a period of six weeks. Follow-up assessments at three and six months post baseline will also be conducted, with secondary outcomes including neural activity (as measured by resting state fMRI), memory (measured using WAIS IV or WISC IV scores) and impulsivity (assessed using UPPS)."
Is enrollment currently open for this research endeavor?
"Per the information on clinicaltrials.gov, this research is not accepting any new participants at present. This trial was initially published on February 20th 2019 and last modified January 7th of the same year. Despite this, there are 137 other studies that are welcoming patients currently."
What criteria do individuals need to meet in order to be included in this research?
"In order to join this clinical trial, patients must be diagnosed with ADHD and aged 6-65. This research is seeking to enroll 240 individuals throughout the duration of the study."
Does this medical experiment accept participants who are over twenty years of age?
"This clinical trial necessitates that applicants are between 6 and 65 years old. Additionally, there exist 98 studies for minors and 28 experiments which focus on individuals over the age of retirement."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger